The investment amount will be treated as an advance and once the
vaccine receives regulatory approvals, SII will include Bangladesh
among the countries who will be the first to receive an agreed
quantity of this vaccine from SII on a priority basis, according to a
press release.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bangladeshs-top-pharma-group-serum-institute-of-india-join-hands-for-covid-19-vaccine/articleshow/77802539.cms
No comments:
Post a Comment